Premarket Biotech Digest – DMPI Receives Approval, PFE Slapped From FDA

DelMar Pharmaceuticals announced that it has received Institutional Review Board approval to conduct a Phase 3 clinical trial. Pfizer received a setback from the FDA. Roche announced receiving the FDA approval .